These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 10564344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fast and slow axonal transport-different methodological approaches give complementary information: contributions of the stop-flow/crush approach.
    Dahlström AB, Li JY.
    Neurochem Res; 1994 Nov; 19(11):1413-9. PubMed ID: 7534876
    [Abstract] [Full Text] [Related]

  • 6. Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations.
    Li W, Hoffman PN, Stirling W, Price DL, Lee MK.
    J Neurochem; 2004 Jan; 88(2):401-10. PubMed ID: 14690528
    [Abstract] [Full Text] [Related]

  • 7. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M.
    J Biol Chem; 1998 Oct 09; 273(41):26292-4. PubMed ID: 9756856
    [Abstract] [Full Text] [Related]

  • 8. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease.
    Bertrand E, Lechowicz W, Lewandowska E, Szpak GM, Dymecki J, Kosno-Kruszewska E, Wierzba-Bobrowicz T.
    Folia Neuropathol; 2003 Oct 09; 41(4):197-207. PubMed ID: 14977249
    [Abstract] [Full Text] [Related]

  • 9. Accumulation of beta- and gamma-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse.
    Wang YL, Takeda A, Osaka H, Hara Y, Furuta A, Setsuie R, Sun YJ, Kwon J, Sato Y, Sakurai M, Noda M, Yoshikawa Y, Wada K.
    Brain Res; 2004 Sep 03; 1019(1-2):1-9. PubMed ID: 15306232
    [Abstract] [Full Text] [Related]

  • 10. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr 03; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 11. Three subpopulations of fast axonally transported retinal ganglion cell proteins are differentially trafficked in the rat optic pathway.
    Mulugeta S, Ciavarra RP, Maney RK, Tedeschi B.
    J Neurosci Res; 2000 Jan 15; 59(2):247-58. PubMed ID: 10650883
    [Abstract] [Full Text] [Related]

  • 12. Mapping of rat brain using the Synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies.
    Andringa G, Du F, Chase TN, Bennett MC.
    J Neuropathol Exp Neurol; 2003 Oct 15; 62(10):1060-75. PubMed ID: 14575241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease.
    Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, Iwatsubo T.
    Neurosci Lett; 1998 Dec 18; 258(2):81-4. PubMed ID: 9875532
    [Abstract] [Full Text] [Related]

  • 16. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
    Chandra S, Fornai F, Kwon HB, Yazdani U, Atasoy D, Liu X, Hammer RE, Battaglia G, German DC, Castillo PE, Südhof TC.
    Proc Natl Acad Sci U S A; 2004 Oct 12; 101(41):14966-71. PubMed ID: 15465911
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.
    Clayton DF, George JM.
    Trends Neurosci; 1998 Jun 12; 21(6):249-54. PubMed ID: 9641537
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.